Fragkiadaki, Evangelia
Katsanou, Lamprini
Vartzoka, Foteini
Gravanis, Achille
Pitsikas, Nikolaos
Funding for this research was provided by:
University of Thessaly Central Library
Article History
Received: 14 June 2023
Accepted: 23 October 2023
First Online: 2 November 2023
Declarations
: The authors declare that the experiments comply with the current laws of Greece.
: All authors, except Achille Gravanis, declare that they have not any competing financial interests in relation to the work described. Dr. Achille Gravanis is the co-founder of spin-off Bionature EA LTD, proprietary of compound BNN27 (patented with the WO 2008/1555 34 A2 number at the World Intellectual Property Organization).